Meritage Portfolio Management’s Idexx Laboratories IDXX Stock Holding History

Meritage Portfolio Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$430K	Hold	635	–	–	0.03%	236
2025 Q3	$406K	Hold	635	–	–	0.03%	251
2025 Q2	$341K	Hold	635	–	–	0.02%	274
2025 Q1	$267K	Hold	635	–	–	0.02%	292
2024 Q4	$263K	Hold	635	–	–	0.02%	298
2024 Q3	$321K	Hold	635	–	–	0.02%	295
2024 Q2	$309K	Hold	635	–	–	0.02%	290
2024 Q1	$343K	Hold	635	–	–	0.02%	282
2023 Q4	$352K	Sell	635 -95	-13%	-$44.6K	0.02%	280
2023 Q3	$319K	Hold	730	–	–	0.02%	276
2023 Q2	$367K	Buy	730 +125	+21%	+$59.9K	0.03%	272
2023 Q1	$303K	Hold	605	–	–	0.02%	259
2022 Q4	$247K	Buy	+605	New	+$235K	0.02%	280
2022 Q3	–	Sell	-605	Closed	-$212K	–	316
2022 Q2	$212K	Hold	605	–	–	0.02%	289
2022 Q1	$331K	Hold	605	–	–	0.02%	253
2021 Q4	$398K	Sell	605 -80	-12%	-$50.2K	0.02%	229
2021 Q3	$426K	Hold	685	–	–	0.03%	220
2021 Q2	$433K	Hold	685	–	–	0.03%	228
2021 Q1	$335K	Hold	685	–	–	0.02%	231
2020 Q4	$342K	Hold	685	–	–	0.03%	221
2020 Q3	$269K	Hold	685	–	–	0.02%	210
2020 Q2	$226K	Buy	+685	New	+$198K	0.02%	202

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Meritage Portfolio Management's IDXX Position: Q4 2025 in Review

Meritage Portfolio Management held its Idexx Laboratories (IDXX) position steady in Q4 2025 at 635 shares worth $430K. The position accounts for 0.03% of the portfolio, ranked #236.

Meritage Portfolio Management first reported a position in IDXX in Q2 2020 and has held it in 22 quarters since. The position peaked at $433K in Q2 2021. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Meritage Portfolio Management held 635 shares of Idexx Laboratories worth $430K as of Q4 2025.
Meritage Portfolio Management left its Idexx Laboratories share count unchanged in Q4 2025.
Idexx Laboratories made up 0.03% of Meritage Portfolio Management's portfolio in Q4 2025, its #236 holding.
Meritage Portfolio Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 22 quarters since.
Meritage Portfolio Management's Idexx Laboratories position peaked at $433K in Q2 2021.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.